Maze Therapeutics, Inc. MAZE

26.05 (0.16) (0.61%) as of 25 Sep
Market cap
$1.5B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22
Cash and Short Term Investments
341.92 196.81 29.16 99.92
Total current assets
349.72 201.67 34.11 106.15
Property, Plant, Equpment (Net)
5.04 6.67 8.85 12.40
Long-Term Investments
18.11 — — —
Long-term assets (Other)
4.14 8.95 2.41 2.58
Total non-current assets
47.41 38.87 37.39 43.81
Total Assets
397.13 240.54 71.50 149.96
Accounts Payable
1.79 1.94 2.02 1.59
Accrued Expenses
15.97 14.10 9.81 14.87
Total current liabilities
22.56 20.67 16.32 20.78
Long Term Debt (Total)
— — 20.08 —
Liabilities (Preferred Stock)
— 508.09 383.90 383.90
Non-current Liabilities (Other)
1.09 0.97 — —
Total non-current liabilities
19.61 531.05 429.04 411.63
Total liabilities
42.16 551.73 445.35 432.42
Additional Paid In Capital
844.35 47.24 21.84 12.81
Common Stock (Net)
0.05 0.00 0.00 0.00
Retained Earnings
(489.55) (358.43) (395.69) (295.27)
Common Equity (Total)
354.97 (311.18) (373.85) (282.46)
Shareholders Equity (Total)
354.97 (311.18) (373.85) (282.46)
Shareholders Equity and Liabilities (Total)
397.13 240.54 71.50 149.96
Shares (Common)
49.34 2.45 2.39 2.37
Shareholders Equity (Tangible)
354.97 (311.18) (373.85) (282.46)
Net Debt
(341.92) (196.81) (9.08) (99.92)
Total Debt
— — 20.08 —

Fold the line items

In millions of $ except per-share values · columns are period end dates